 |
| MJNA Drives Towards EU Approval. Massive New Market for Products! |
|
|
 Yesterday's Top Performer |
Company: Get Real USA Inc. (Pink Sheets: GTRL)
|
End of Day:
Price: 0.026
Change (%): + 0.01 (62.50)
Volume: 77,537
|
 |
A publicly-traded Company on the OTC, Symbol: GTRL, is engaged in the production of low-budget, high quality, genre pictures with recognizable name talent. Our management team and board are comprised of industry professionals, whose experience spans decades in the industry.
Our team is relentless in carrying out their mission of protecting the Company's financial investments by focusing on reducing risk and maximizing profitability. The Get Real USA Entertainment division's financing strategy is "low risk", supported by government incentives, as well as partially funded by well-known film distribution partners.
Continue Reading
|
 Hot Stock to Watch |
Company: Medical Marijuana Inc. (Pink Sheets: MJNA)
|
End of Day:
Price: 0.0275
Change (%): - 0.001 (3.51)
Volume: 748,115
|
 |
Medical Marijuana Inc. and Canipa Holdings Drive Dixie X and CanChew Gum Toward EU Marketing Approval And Clinical Development
SAN DIEGO, Aug. 1, 2012 /PRNewswire/ -- Medical Marijuana Inc. (OTC: MJNA), a leading hemp industry innovator, is pleased to provide an update on the efforts of Canipa Holdings in regards to European Union marketing approvals for MJNA Portfolio Products including the Dixie X Brand and CanChew gum.
Approval Process
Canipa Holdings is currently working with European Health Authorities and their Governmental counterparts to obtain marketing approvals for the Dixie X and CanChew gum hemp-based, CBD-infused products. We expect preliminary approval in 60 days and final approval 30 days after. Once approved, these products will be sold "over-the-counter" throughout Romania and the remaining 26 European Union Member Countries.
Continue Reading
|
Other Small Cap News
|
Company: Alseres Pharmaceuticals, Inc. (OTCQB: ALSE)
|
Alseres Pharmaceuticals, Inc. Reports License of Altropane® Worldwide Rights to Navidea Biopharmaceuticals, Inc.
Conference Call to be Held Wednesday, August 1, 2012 at 11:00 a.m. Eastern Daylight Time
HOPKINTON, Mass., July 31, 2012 /PRNewswire/ -- Alseres Pharmaceuticals, Inc. (OTC: ALSE) today announced that it has entered into an agreement with Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB, "Navidea") to license, [123I]-E-IACFT Injection (CFT), also called Altropane®, an Iodine-123 radiolabeled imaging agent, being developed as an aid in the diagnosis of Parkinson's disease and movement disorders.
Continue Reading
|
Company: NanoTech Entertainment (Pink Sheets: NTEK)
|
NanoTech Entertainment (NTEK) Launches TV Show Starring Adam Curry
First TV Show for NanoTech's Media Division Featuring Former MTV Star Released on Roku Platform
LAS VEGAS, Aug. 1, 2012 /PRNewswire/ -- NANOTECH ENTERTAINMENT (PINKSHEETS: NTEK) today has announced its first ever television show - "Adam Curry's Big App Show," is now available and prominently featured on the Roku IPTV platform. This daily video features reviews of new and interesting apps for iPhone, iPad and Android devices narrated by Adam Curry, who became an overnight media sensation as a VJ on MTV in the late 1980s.
Continue Reading
|
Company: Reservoir Minerals Inc. (Pink Sheets: RVRLF)
|
Reservoir Minerals Inc.: Phase 2 Soil Geochemical Sampling Successfully Completed at the Bibemi Project in Cameroon
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Aug. 1, 2012) - Reservoir Minerals Inc. (TSX VENTURE:RMC) (PINKSHEETS:RVRLF) (BERLIN:9RE) ("RMC" or the "Company"), is pleased to announce results from the Phase 2A soil sampling campaign in the Bibemi Exploration License in northern Cameroon. Gold anomalous soil samples define a strike length of approximately 11 kilometers within the prospective Archean greenstone terrain that was identified by the earlier stream sediment sampling campaign (see Company News Release, dated July 3, 2011).
Continue Reading
|
Company: Imogo Mobile Technologies Corp. (OTCBB: IMTC)
|
Imogo's cloud based applications optimized for new Samsung Galaxy S3 and upcoming Apple iPhone 5
SEATTLE, Aug. 1, 2012 /PRNewswire/ -- Imogo Mobile Technologies Corp. (OTCBB: IMTC), the leader in secure mobile cloud services, announced today that their new cloud based applications, which allow people to work from any device at anytime, anywhere with an internet connection, have been optimized for the new Samsung Galaxy S3 and upcoming Apple iPhone 5. PR Newswire
Continue Reading
|
Market News
|
By Jeff Macke: Breakout
|
Apple's iPhone 5: Get Ready to Go Gaga
Apple (AAPL) shares rallied on Tuesday as rumors surfaced that the company will hold a "special event" in San Francisco on September 12. It is widely assumed the star of the show will be the iPhone 5, expected to be the first radical makeover of the smartphone since 2010. The buzz sent Apple's stock back above $600, more than recovering losses suffered in the wake of a disappointing earnings release last week.
Jon Najarian co-founder of TradeMonster.com says the potential not just for a new phone but also a smaller version of the iPad has investors in a tizzy. "The stock could be closer to $700 on September 12th if they announced both; but I don't think they will," Najarian says in the attached clip.
Continue Reading
|
By Craig Torres and Ilan Kolet: Bloomberg
|
Ghost of 2008 Haunts Fed as Companies Take Short View on Risk
United Parcel Service Inc. (UPS) computer systems monitoring the heartbeat of global commerce sent a discouraging message last quarter as package flows began to fall below the company's forecast.
On July 24 executives announced that they were reducing their Asian air network by 10 percent. Domestic routes were also fine-tuned to lower volumes by systems called Volcano and HFNO that efficiently plan how packages move on planes and trucks to consumers' doorsteps.
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the “unsubscribe” link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks
|
